MENU
LVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

LAVA Therapeutics (LVTX) Ownership - Who owns LAVA Therapeutics?

LAVA Therapeutics NV isa clinical stage immuno-oncology company... Show more

Profile

Industry
N/A
Address
Yalelaan 62
Phone
+31 850163100
Employees
35
Web
https://www.lavatherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
34.46M
P/E Ratio
N/A
Total Cash
66.56M
Projected Growth
N/A
Total Debt
312K
Revenue
4.99M
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash/Share
2.53
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price

Fundamentals

LVTX
Capitalization
34.5M
P/E Ratio
N/A
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash
66.6M
Total Cash/Share
2.53
Total Debt
312K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
4.99M
ROE
N/A
Book Value
25.8M
P/B Ratio
1.34
Cash Flow
N/A
Earnings
-1.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.72M
Current Ratio
6.73
Current Revenue Per Employee
188972.97
Dividends Per Share - Security
N/A
EBITDA
-26.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-32.88
Shares Held By Institutions
10.3M
Shares Outstanding - Current
26.3M
Total Liabilities
45.4M
Total Volume MTD
N/A
Value
1
Gain YTD
37.224
View a ticker or compare two or three
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Yalelaan 62
Phone
+31 850163100
Employees
35
Web
https://www.lavatherapeutics.com